BeOne Medicines Ltd.

NASDAQ: ONC · Real-Time Price · USD
266.77
9.26 (3.60%)
At close: Jun 24, 2025, 3:59 PM
268.05
0.48%
Pre-market: Jun 25, 2025, 04:22 AM EDT

BeOne Medicines Statistics

Share Statistics

BeOne Medicines has 99.37M shares outstanding. The number of shares has increased by null% in one year.

99.37M
n/a
n/a
n/a
n/a
1,009
0.23%

Short Selling Information

The latest short interest is 2.03M, so 1.88% of the outstanding shares have been sold short.

2.03M
1.88%
2.69%
7.59

Valuation Ratios

The PE ratio is -30.16 and the forward PE ratio is 38.52. BeOne Medicines's PEG ratio is 1.09.

-30.16
38.52
5.1
4.3
5.84
-29.04
1.09
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BeOne Medicines.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.32.

1.8
1.58
0.32
-2.72
-1.61
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$346,385.55
$-58,616.91
11,000
0.64
1.2

Taxes

111.78M
-20.97%

Stock Price Statistics

The stock price has increased by 76.68% in the last 52 weeks. The beta is 0.29, so BeOne Medicines's price volatility has been higher than the market average.

0.29
76.68%
246.14
224.74
59.16
443,935

Income Statement

In the last 12 months, BeOne Medicines had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -6.12.

3.81B
3.22B
-568.2M
-644.79M
-396.44M
-568.2M
-6.12
Full Income Statement

Balance Sheet

The company has 2.63B in cash and 1.08B in debt, giving a net cash position of 1.55B.

2.63B
1.08B
1.55B
-8.61B
5.84B
1.91B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -140.63M and capital expenditures -529.14M, giving a free cash flow of -669.77M.

-140.63M
-529.14M
-669.77M
-0.49
Full Cash Flow Statement

Margins

Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.

84.41%
-14.91%
-13.99%
-16.92%
-10.4%
-14.91%
-17.58%

Dividends & Yields

ONC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ONC is $325.5, which is 22% higher than the current price. The consensus rating is "Buy".

$325.5
22%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

5.75
5